VivaQuant
Software DevelopmentMinnesota, United States11-50 Employees
VivaQuant develops software tools for quantitative ECG analysis used in biomedical and drug-safety research, and it also operates a services group that provides end-to-end evaluation of arrhythmia risk and quantification of cardiac intervals. The offering centers on MDSP technology, which eliminates 95% of noise while preserving fidelity, enabling precise measurements from continuous ambulatory ECG data where artifact and signal degradation are common. The company primarily serves researchers and product teams in pharmaceutical and biomedical fields seeking objective assessments of arrhythmia liability. By reducing noise and artifacts in ambulatory ECGs, VivaQuant’s software and services support more sensitive and accurate analyses. Based in St. Paul, Minnesota, the firm is a small to mid-sized software development operation. In 2021, VivaQuant was named a finalist for the Tekne Awards.